Trusted News Discovery Since 2008
{{/content}}
Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
Credit: Business Wire- Published 2 weeks ago
SARASOTA, Fla.--(BUSINESS WIRE)--Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the โNoticeโ) from the NYSE American LLC (the โNYSE Americanโ) dated April 18, 2024, notifying the Company that it is no longer in compliance with NYSE American continued listing standards. Specifically, the letter states that the Company is not in compliance with the con